Centessa Pharmaceuticals Files 8-K on Financials

Ticker: CNTA · Form: 8-K · Filed: Mar 24, 2025 · CIK: 1847903

Centessa Pharmaceuticals PLC 8-K Filing Summary
FieldDetail
CompanyCentessa Pharmaceuticals PLC (CNTA)
Form Type8-K
Filed DateMar 24, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, results-of-operations, filing

Related Tickers: CNTA

TL;DR

Centessa Pharma dropped an 8-K on March 24th detailing their financials. Check it out.

AI Summary

Centessa Pharmaceuticals plc filed an 8-K on March 24, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Altrincham, Cheshire, United Kingdom.

Why It Matters

This filing provides an update on Centessa Pharmaceuticals' financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any significant new risks or negative developments.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Centessa Pharmaceuticals plc's Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.

When was this 8-K filing submitted?

This 8-K filing was submitted on March 24, 2025.

Where are Centessa Pharmaceuticals plc's principal executive offices located?

Centessa Pharmaceuticals plc's principal executive offices are located at 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, WA14 2DT, United Kingdom.

What is the Commission File Number for Centessa Pharmaceuticals plc?

The Commission File Number for Centessa Pharmaceuticals plc is 001-40445.

What is the Standard Industrial Classification (SIC) code for Centessa Pharmaceuticals plc?

The Standard Industrial Classification (SIC) code for Centessa Pharmaceuticals plc is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 24, 2025 regarding Centessa Pharmaceuticals plc (CNTA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing